# External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma

> **NCT00271050** · PHASE1 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 12 (estimated)

## Conditions studied

- Lymphoma, B-Cell

## Interventions

- **OTHER:** external beam radiotherapy plus 90-Y ibritumomab tiuxetan

## Key facts

- **NCT ID:** NCT00271050
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-12
- **Final completion:** 2010-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271050, "External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00271050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*